4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-010831
CHIEF OPERATING OFFICER sold 17,500 shares at $25.03 ($438,099)
- CHIEF OPERATING OFFICER acquired 14,903 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Patel Anish · CHIEF OPERATING OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,903 | $2.48 | $36,959 | 17,500 | D |
| 2024-04-11 | Sale : show line 2 in the form 10b5-1 | −17,500 | $25.03 | $438,099 | 0 | D |
| Open-market sales · 17,500 sh · avg $25.03 · $438,099 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-11 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) | −14,903 | 60,717 | D |
Loading xslF345X05/form4-04152024_110448.xml…